Progected coverage for 2030: Is it time to catch-up for HPV vaccine in brazilian woman?
DOI:
https://doi.org/10.33448/rsd-v11i16.38265Keywords:
Human papillomavirus; Papillomavirus vaccines; Vaccination coverage; Brazil.Abstract
Ensuring vaccination of approximately 90% of adolescents for the human papillomavirus (HPV) by 2030 is a key strategy put forth by the World Health Organization (WHO) for the elimination of cervical cancer. This study aims to analyze the extent of vaccination in 25– 29-year old women by 2030, considering that the vaccination campaign began in 2014. Data regarding the HPV vaccination of women born between 2001 and 2005 were obtained from the Information System of the Ministry of Health on the female population projection for 2026–2030. Considering only the first dosage, the South, Southeast, and Northeast regions will have reached the target of 90% coverage. However, regarding the second dose, only the Southeast region was have reached the 89.7% target in 2030. However, the Midwest and North regions will only have 68.8% and 67.01% coverage, respectively; therefore, the vaccination drive must be strictly implement for these regions.
References
Basu, P., Malvi, S. G., Joshi, S., Bhatla, N., Muwonge, R., Lucas, E., Verma, Y., Esmy, P. O., Poli, U. R. R., Shah, A., Zomawia, E., Pimple, S., Jayant, K., Hingmire, S., Chiwate, A., Divate, U., Vashist, S., Mishra, G., Jadhav, R., … Sankaranarayanan, R. (2021). Vaccine efficacy against persistent human papillomavirus (HPV) 16/18 infection at 10 years after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre, prospective, cohort study. The Lancet Oncology, 22(11), 1518–1529.
Bruni, L., Saura-Lázaro, A., Montoliu, A., Brotons, M., Alemany, L., Diallo, M. S., Afsar, O. Z., LaMontagne, D. S., Mosina, L., Contreras, M., Velandia-González, M., Pastore, R., Gacic-Dobo, M., & Bloem, P. (2021). HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010-2019. Preventive Medicine, 144, 106399.
Drolet, M., Laprise, J.-F., Martin, D., Jit, M., Bénard, É., Gingras, G., Boily, M.-C., Alary, M., Baussano, I., Hutubessy, R., & Brisson, M. (2021). Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources: a mathematical modelling analysis. The Lancet Infectious Diseases, 21(11), 1598–1610.
Eliès, A., Bonneau, C., Houzard, S., Rouzier, R., & Héquet, D. (2022). Impact of catch-up human papillomavirus vaccination on cervical conization rate in a real-life population in France. PloS One, 17(3), e0264821.
Kang, W. D., Choi, H. S., & Kim, S. M. (2013). Is vaccination with quadrivalent HPV vaccine after loop electrosurgical excision procedure effective in preventing recurrence in patients with high-grade cervical intraepithelial neoplasia (CIN2-3)? Gynecologic Oncology, 130(2), 264–268.
Kreimer, A. R., Herrero, R., Sampson, J. N., Porras, C., Lowy, D. R., Schiller, J. T., Schiffman, M., Rodriguez, A. C., Chanock, S., Jimenez, S., Schussler, J., Gail, M. H., Safaeian, M., Kemp, T. J., Cortes, B., Pinto, L. A., Hildesheim, A., Gonzalez, P., & Costa Rica HPV Vaccine Trial (CVT) Group. (2018). Evidence for single-dose protection by the bivalent HPV vaccine-Review of the Costa Rica HPV vaccine trial and future research studies. Vaccine, 36(32 Pt A), 4774–4782.
Liu, G., Mugo, N. R., Bayer, C., Rao, D. W., Onono, M., Mgodi, N. M., Chirenje, Z. M., Njoroge, B. W., Tan, N., Bukusi, E. A., & Barnabas, R. V. (2022). Impact of catch-up human papillomavirus vaccination on cervical cancer incidence in Kenya: A mathematical modeling evaluation of HPV vaccination strategies in the context of moderate HIV prevalence. EClinicalMedicine, 45, 101306.
Pavlin, N. L., Gunn, J. M., Parker, R., Fairley, C. K., & Hocking, J. (2006). Implementing chlamydia screening: what do women think? A systematic review of the literature. BMC Public Health, 6, 221.
Rebolj, M., Pesola, F., Mathews, C., Mesher, D., Soldan, K., & Kitchener, H. (2022). The impact of catch-up bivalent human papillomavirus vaccination on cervical screening outcomes: an observational study from the English HPV primary screening pilot. British Journal of Cancer. https://doi.org/10.1038/s41416-022-01791-w
Soares, L. C., & Brollo, J. L. A. (2016). Response to: Survey of Japanese mothers of daughters eligible for human papillomavirus vaccination on attitudes about media reports of adverse events and the suspension of governmental recommendation for vaccination. The Journal of Obstetrics and Gynaecology Research, 42(5), 593–594.
Sousa, D. M. D. N., Chagas, A. C. M. A., Vasconcelos, C. T. M., Stein, A. T., & Oriá, M. O. B. (2018). Development of a clinical protocol for detection of cervical cancer precursor lesions. Revista latino-americana de enfermagem, 26, e 2999.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Adriana do Valle Graca; Leila Cristina Soares
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
